Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
Add more filters










Publication year range
1.
Mol Cancer Ther ; 18(3): 680-692, 2019 03.
Article in English | MEDLINE | ID: mdl-30587555

ABSTRACT

A major caveat in the treatment of breast cancer is disease recurrence after therapeutic regime at both local and distal sites. Tumor relapse is attributed to the persistence of chemoresistant cancer stem cells (CSC), which need to be obliterated along with conventional chemotherapy. Wedelolactone, a naturally occurring coumestan, demonstrates anticancer effects in different cancer cells, although with several limitations, and is mostly ineffective against CSCs. To enhance its biological activity in cancer cells and additionally target the CSCs, wedelolactone-encapsulated PLGA nanoparticles (nWdl) were formulated. Initial results indicated that nanoformulation of wedelolactone not only increased its uptake in breast cancer cells and the CSC population, it enhanced drug retention and sustained release within the cells. Enhanced drug retention was achieved by downregulation of SOX2 and ABCG2, both of which contribute to drug resistance of the CSCs. In addition, nWdl prevented epithelial-to-mesenchymal transition, suppressed cell migration and invasion, and reduced the percentage of breast cancer stem cells (BCSC) in MDA-MB-231 cells. When administered in combination with paclitaxel, which is known to be ineffective against BCSCs, nWdl sensitized the cells to the effects of paclitaxel and reduced the percentage of ALDH+ BCSCs and mammospheres. Furthermore, nWdl suppressed growth of solid tumors in mice and also reduced CD44+/CD24-/low population. Taken together, our data imply that nWdl decreased metastatic potential of BCSCs, enhanced chemosensitivity through coordinated regulation of pluripotent and efflux genes, and thereby provides an insight into effective drug delivery specifically for obliterating BCSCs.


Subject(s)
ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics , Breast Neoplasms/drug therapy , Coumarins/pharmacology , Neoplasm Proteins/genetics , SOXB1 Transcription Factors/genetics , Animals , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cell Movement/drug effects , Cell Proliferation/drug effects , Coumarins/chemistry , Drug Resistance, Neoplasm/genetics , Epithelial-Mesenchymal Transition/drug effects , Female , Gene Expression Regulation, Neoplastic/drug effects , Heterografts , Humans , MCF-7 Cells , Mice , Nanoparticles/administration & dosage , Nanoparticles/chemistry , Neoplasm Recurrence, Local/drug therapy , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Neoplastic Stem Cells/drug effects , Paclitaxel/pharmacology
2.
Indian J Med Res ; 144(2): 181-193, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27934796

ABSTRACT

Current treatment methods for melanoma have some limitations such as less target-specific action, severe side effects and resistance to drugs. Significant progress has been made in exploring novel drug delivery systems based on suitable biochemical mechanisms using nanoparticles ranging from 10 to 400 nm for drug delivery and imaging, utilizing their enhanced penetration and retention properties. Poly-lactide-co-glycolide (PLGA), a copolymer of poly-lactic acid and poly-glycolic acid, provides an ideally suited performance-based design for better penetration into skin cells, thereby having a greater potential for the treatment of melanoma. Moreover, encapsulation protects the drug from deactivation by biological reactions and interactions with biomolecules, ensuring successful delivery and bioavailability for effective treatment. Controlled and sustained delivery of drugs across the skin barrier that otherwise prohibits entry of larger molecules can be successfully made with adequately stable biocompatible nanocarriers such as PLGA for taking drugs through the small cutaneous pores permitting targeted deposition and prolonged drug action. PLGA is now being extensively used in photodynamic therapy and targeted therapy through modulation of signal proteins and drug-DNA interactions. Recent advances made on these nanomedicines and their advantages in the treatment of skin melanoma are highlighted and discussed in this review.


Subject(s)
Drug Delivery Systems , Lactic Acid/therapeutic use , Melanoma/drug therapy , Nanoparticles/therapeutic use , Polyglycolic Acid/therapeutic use , Humans , Lactic Acid/chemistry , Melanoma/pathology , Nanomedicine , Nanoparticles/chemistry , Polyglycolic Acid/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer
3.
J Pharmacopuncture ; 19(1): 37-44, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27280048

ABSTRACT

OBJECTIVES: This study examined the relative efficacies of a derivative of betulinic acid (dBA) and its poly (lactide- co-glycolide) (PLGA) nano-encapsulated form in A549 lung cancer cells in vivo and in co-mutagen [sodium arsenite (SA) + benzo]undefined[a]pyrene (BaP)]-induced lung cancer in mice in vivo. METHODS: dBA was loaded with PLGA nanoparticles by using the standard solvent displacement method. The sizes and morphologies of nano-dBA (NdBA) were determined by using transmission electron microscopy (TEM), and their intracellular localization was verified by using confocal microscopy. The binding and interaction of NdBA with calf thymus deoxyribonucleic acid (CT-DNA) as a target were analyzed by using conventional circular dichroism (CD) and melting temperature (Tm) profile data. Apoptotic signalling cascades in vitro and in vivo were studied by using an enzyme-linked immunosorbent assay (ELISA); the ability of NdBA to cross the blood-brain barrier (BBB) was also examined. The stage of cell cycle arrest was confirmed by using a fluorescence-activated cell-sorting (FACS) data analysis. RESULTS: The average size of the nanoparticles was ~ 110 nm. Confocal microscopy images confirmed the presence of NdBA in the cellular cytoplasm. The bio-physical properties of dBA and NdBA ascertained from the CD and the Tm profiles revealed that NdBA had greater interaction with the target DNA than dBA did. Both dBA and NdBA arrested cell proliferation at G0/G1, NdBA showing the greater effect. NdBA also induced a greater degree of cytotoxicity in A549 cells, but it had an insignificant cytotoxic effect in normal L6 cells. The results of flow cytometric, cytogenetial and histopathological studies in mice revealed that NdBA caused less nuclear condensation and DNA damage than dBA did. TEM images showed the presence of NdBA in brain samples of NdBA fed mice, indicating its ability to cross the BBB. CONCLUSION: Thus, compared to dBA, NdBA appears to have greater chemoprotective potential against lung cancer.

4.
J Acupunct Meridian Stud ; 7(3): 140-50, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24929458

ABSTRACT

We isolated a triterpenoid from an ethanolic extract of Phytolacca decandra and nanoencapsulated it with biodegradable nontoxic polymers of poly(lactide-co-glycolide) to examine if the nanoform of this hitherto unexplored betulinic-acid derivative (NdBA) could produce a stronger anticancer effect by rendering better drug bioavailability and targeted delivery than the nonencapsulated betulinic-acid derivative (dBA). The nanoparticles were characterized with the help of physicochemical and morphological studies involving dynamic light scattering and atomic force microscopy. A549 cancer cells were exposed to NdBA and dBA at the IC50 doses of 50 µg/mL and 100 µg/mL, respectively. Mitochondrial dysfunction-mediated apoptosis was determined by examining the changes in the intracellular calcium content, the reactive oxygen species accumulation, the cytochrome c release, the upregulation of Bcl-2-associated-X protein (Bax) and caspase 3, the downregulation of B cell lymphoma 2, and the mitochondrial membrane potential (ΔΨm) depolarization. Apoptosis was also verified by acridine orange staining observed under fluorescence microscopy and annexin V-fluorescein isothiocyanate/propidium iodide staining through flow cytometric studies. The levels of intracellular adenosine triphosphate/adenosine diphosphate ratio decreased, and the ATPase activity increased more strikingly in A549 cells exposed to NdBA than in A549 cells exposed to dBA. Overall results showed that both drugs directly target the mitochondrial oxidative phosphorylation system, with NdBA having a stronger effect, indicating NdBA to be a better candidate for the development of an anticancer drug for use against lung adenocarcinomas.


Subject(s)
Adenocarcinoma/drug therapy , Apoptosis/drug effects , Carcinoma, Non-Small-Cell Lung/drug therapy , Mitochondria/drug effects , Phytolacca/chemistry , Phytotherapy , Triterpenes/therapeutic use , Adenocarcinoma/metabolism , Adenosine Triphosphatases/metabolism , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/therapeutic use , Biological Availability , Calcium/metabolism , Carcinoma, Non-Small-Cell Lung/metabolism , Cell Line, Tumor , Humans , Membrane Potential, Mitochondrial/drug effects , Mitochondria/metabolism , Nanoparticles , Oxidative Phosphorylation/drug effects , Pentacyclic Triterpenes , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Triterpenes/isolation & purification , Triterpenes/pharmacology , Betulinic Acid
5.
Nutr Cancer ; 66(2): 194-205, 2014.
Article in English | MEDLINE | ID: mdl-24377653

ABSTRACT

In recent years, there has been growing interest in cancer prevention by food plants and their products. Although several plant parts have potentials for chemoprevention and other therapeutic use, their molecular mechanisms of action are not always well understood. Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer. In this review, we accumulate evidences of modulating abilities of some dietary plants and their products on several signaling pathways, including the inflammatory and apoptotic ones, which may be targeted for cancer therapy. We have mainly focused on several phytochemicals like resveratrol (red grapes and peanuts), allicin (garlic), lycopene (tomato), indole-3-carbinol (cruciferous vegetables), vitamin C (citrus fruits), [6]-gingerol (ginger), emodin (aloe), natural antioxidant mixture (spinach), beta carotenoids (carrots), sulphoraphane (mustard), ellagic acid (pomegranate), myrecitin (cranberry), carnosol (rosemary), vanillin (vanilla) and eugenol (cloves). They act through one or more signaling pathways like nuclear factor kappa B, cyclooxygenase-2, signal transducer and activator of transcription 3, Akt, mitogen activated protein kinase/extracellular regulated kinase, Bcl-2, caspases, poly (ADP-ribose) polymerase, matrix metalloproteinase 2/9, and cyclin D1. Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs.


Subject(s)
Neoplasms/prevention & control , Plants, Edible/chemistry , Angiogenesis Inducing Agents/pharmacology , Antioxidants/pharmacology , Apoptosis/drug effects , Cell Cycle/drug effects , Chemoprevention , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Extracellular Signal-Regulated MAP Kinases/genetics , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Inflammation/prevention & control , NF-kappa B/genetics , NF-kappa B/metabolism , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Poly(ADP-ribose) Polymerases/genetics , Poly(ADP-ribose) Polymerases/metabolism , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Reactive Oxygen Species/metabolism , Signal Transduction
6.
Toxicol Lett ; 225(3): 454-66, 2014 Mar 21.
Article in English | MEDLINE | ID: mdl-24440344

ABSTRACT

Activation of signal transducer and activator of transcription3 (STAT3) is a hallmark of several types of cancer. Failure to inhibit STAT3 expression by injection of siRNA for STAT3 directly to Balb/c mice led us to adopt alternative means. We formulated nanoparticle-based encapsulation of siRNA (NsiRNA) with polyethylenimine (PEI) and poly(lactide-co-glycolide) (PLGA) and characterized them. The siRNA treated and NsiRNA-treated cells were subjected separately to different assay systems. We also checked if NsiRNA could cross the blood brain barrier (BBB). Cell viability reduced dramatically in A549 cells after NsiRNA administration (23.89% at 24 h), thereby implicating considerable silencing of STAT3 by NsiRNA, but not after siRNA administration. Compared to controls, a significant decrease in expression of IL-6 and the angiogenic factor (VEGF) and increase in Caspase 3 activity was observed with corresponding regression in tumor growth in mice treated with NsiRNA. NsiRNA induced apoptosis of cells and arrested cells at G1/G0 stage, both in vitro and in vivo. Apoptosis was also verified by Annexin-V-FITC/Propidium-iodide staining. NsiRNA could cross blood brain barrier. Overall results revealed PEI-PLGA to be a promising carrier for delivery of siRNA targeting STAT3 expression, which can be utilized as an effective strategy for cancer therapy.


Subject(s)
Drug Delivery Systems/methods , Lung Neoplasms/therapy , Nanoparticles/administration & dosage , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/genetics , STAT3 Transcription Factor/genetics , Animals , Caspase 3/genetics , Caspase 3/metabolism , Cell Cycle Checkpoints/physiology , Cell Line, Tumor , Cell Survival/physiology , Flow Cytometry , Gene Silencing , Humans , Interleukin-6/genetics , Interleukin-6/metabolism , Lung Neoplasms/drug therapy , Lung Neoplasms/genetics , Mice , Mice, Inbred BALB C , Molecular Targeted Therapy , Polyethyleneimine/pharmacology , Polyglycolic Acid/pharmacology , RNA/chemistry , RNA/genetics , Reverse Transcriptase Polymerase Chain Reaction , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
7.
J Integr Med ; 11(6): 405-15, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24299604

ABSTRACT

OBJECTIVE: To test if myricanone (C21H24O5), a cyclic diarylheptanoid, has anticancer effects on two different cancer cell lines HeLa and PC3. The present study was conducted with a note on the drug-DNA interaction and apoptotic signalling pathway. METHODS: Several studies like cytotoxicity, nuclear damage, annexin-V-fluorescein isothiocyanate (FITC)/propidium iodide (PI)-labelled apoptotic assay and cell cycle arrest, immunoblot and reverse transcriptase-polymerase chain reaction (RT-PCR) were used following standard protocols. Circular dichroism (CD) spectroscopy was also done to evaluate whether myricanone effectively interacted with DNA to bring about conformational changes that could strongly inhibit the cancer cell proliferation. RESULTS: Myricanone showed a greater cytotoxic effect on PC3 cells than on HeLa cells. Myricanone promoted G0/G1 arrest in HeLa cells and S phase arrest in PC3 cells. Nuclear condensation and annexin V-FITC/PI studies revealed that myricanone promoted apoptotic cell death. CD spectroscopic data indicated that myricanone had an interaction with calf thymus DNA that changed DNA structural conformation. RT-PCR and immunoblot studies revealed that myricanone activated the apoptotic signalling cascades through down-regulation of transcription factors like nuclear factor-κB (NF-κB) (p65), and signal transducers and activators of transcription 3 (STAT3); cell cycle regulators like cyclin D1, and survivin and other signal proteins like Bcl-2 and up-regulation of Bax, caspase-9 and caspase-3. CONCLUSION: Myricanone induced apoptosis in both types of cancer cells by triggering caspase activation, and suppression of cell proliferation by down-regulation of NF-κB and STAT3 signalling cascades, which makes it a suitable candidate for possible use in the formulation of therapeutic agent for combating cancer.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , DNA/metabolism , Diarylheptanoids/pharmacology , Myrica/chemistry , Plant Extracts/analysis , Apoptosis/drug effects , Cell Cycle/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Circular Dichroism , Diarylheptanoids/metabolism , Female , Humans , Male , Signal Transduction , Spectroscopy, Fourier Transform Infrared
8.
Food Chem Toxicol ; 62: 670-80, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24120900

ABSTRACT

Skin cancer is increasing at an alarming rate and becoming resistant to conventional chemotherapy necessitating improved drug delivery system. We loaded apigenin (Ap), a dietary flavonoid having anti-cancer property, with poly (lactic-co-glycolide) (PLGA) nanoparticles (NAp) to explore if nano-encapsulation could enhance anti-carcinogenic effect against ultra-violet B (UVB) and Benzo(a)pyrene (BaP) induced skin tumor and mitochondrial dysfunction in mice. Particle size, morphology and zeta potential of NAp were determined using dynamic light scattering and atomic force microscopy. Tumor incidence and multiplicity in UVB-BaP induced mice with/without NAp treatment were ascertained and their histolopathological sections and chromosomal aberrations were studied. ROS accumulation and mitochondrial functioning through relevant markers like mitochondrial transmembrane potential were analyzed. Mitochondrial volume changes/swelling, cytochrome c (cyt c) release, mRNA and protein expressions of Apaf-1, bax, bcl-2, cyt c, cleaved caspase-9 and 3 were studied. Results showed that NAp produced better effects than Ap, due to their smaller size, and faster mobility. NAp reduced tissue damage and frequency of chromosomal aberrations, increased ROS accumulation to mediate mitochondrial-apoptosis through modulation of several apoptotic markers and mitochondrial matrix swelling. NAp showed ameliorative potentials in combating skin cancer and therefore has greater prospect of use in therapeutic management of skin cancer.


Subject(s)
Anticarcinogenic Agents/pharmacology , Apigenin/pharmacology , Benzo(a)pyrene/toxicity , Lactic Acid/administration & dosage , Mitochondria/drug effects , Nanoparticles/administration & dosage , Polyglycolic Acid/administration & dosage , Skin Neoplasms/drug therapy , Animals , Anticarcinogenic Agents/administration & dosage , Apigenin/administration & dosage , Apoptosis/drug effects , Drug Carriers , Membrane Potential, Mitochondrial/drug effects , Mice , Mitochondria/metabolism , Nanoparticles/chemistry , Neoplasms, Radiation-Induced/drug therapy , Neoplasms, Radiation-Induced/metabolism , Polylactic Acid-Polyglycolic Acid Copolymer , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Skin Neoplasms/chemically induced , Skin Neoplasms/metabolism , Ultraviolet Rays
9.
J Acupunct Meridian Stud ; 6(5): 252-62, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24139463

ABSTRACT

In this study, we examined the antioxidative and the DNA protective potentials of apigenin, a flavonoid polyphenol isolated from Lycopodium clavatum, in both in-vitro (HaCaT skin keratinocytes) and in-vivo (mice) models against UV-B radiation. We used DAPI staining in UV-B-irradiated HaCaT skin keratinocytes pre-treated with and without apigenin to assess DNA damage. We also used a flow-cytometric analysis in mice exposed to UV-B radiation with or without topical application of apigenin to assess, through a comet assay, chromosomal aberrations and quanta from reactive oxygen species (ROS) generation. Data from the stability curves for the Gibb's free energy determined from a melting-temperature profile study indicated that apigenin increased the stability of calf thymus DNA. Immunofluorescence studies revealed that apigenin caused a reduction in the number of cyclobutane pyrimidine dimers (CPDs) after 24 h, the time at which the nucleotide excision repair (NER) genes were activated. Thus, apigenin accelerated reversal of UV-B-induced CPDs through up-regulation of NER genes, removal of cyclobutane rings, inhibition of ROS generation, and down-regulation of NF-κB and MAPK, thereby revealing the precise mechanism of DNA repair.


Subject(s)
Apigenin/pharmacology , DNA Damage/drug effects , DNA Repair/drug effects , Lycopodium/chemistry , Protective Agents/pharmacology , Animals , Cell Line , Cell Survival/drug effects , Humans , Keratinocytes/drug effects , Mice , Plant Extracts/pharmacology , Pyrimidine Dimers/metabolism , Random Allocation , Reactive Oxygen Species/metabolism , Skin/drug effects , Skin/metabolism , Thermodynamics , Ultraviolet Rays
10.
Toxicol Lett ; 223(2): 124-38, 2013 Nov 25.
Article in English | MEDLINE | ID: mdl-24070738

ABSTRACT

The aim of the present study was the evaluation of anti-proliferative potentials of apigenin (Ap), (a dietary flavonoid) loaded in poly (lactic-co-glycolide) nanoparticles (NAp) in A375 cells in vitro. NAp was characterized for particle size, morphology, zeta potential, drug release and encapsulation. Cellular entry and intracellular localization of NAp were assessed by transmission electron and confocal microscopies. Circular dichroic spectral analysis and stability curve for Gibb's free energy of dsDNA of A375 cells were also analyzed. DNA fragmentation, intracellular ROS accumulation, superoxide-dismutase activity, intracellular glutathione-reductase content and mitochondrial functioning through relevant markers like mitochondrial transmembrane potential, ATPase activity, ATP/ADP ratio, volume changes/swelling, cytochrome-c release, expressions of Apaf-1, bax, bcl-2, caspase-9, 3, and PARP cleavage were analyzed. NAp produced better effects due to their smaller size, faster mobility and site-specific action. Photostability studies revealed that PLGA encapsulations were efficient at preserving apigenin ultraviolet-light mediated photodegradation. NAp readily entered cancer cells, could intercalate with dsDNA, inducing conformational change. Corresponding increase in ROS accumulation and depletion of the antioxidant enzyme activities exacerbated DNA damage, mediating apoptosis through mitochondrial dysfunction. Overall results indicate that therapeutic efficacy of NAp may be enhanced by PLGA nanoparticle formulations to have better ameliorative potentials in combating skin melanoma.


Subject(s)
Apigenin/pharmacology , Lactic Acid/chemistry , Melanoma/drug therapy , Nanoparticles/chemistry , Polyglycolic Acid/chemistry , Apigenin/chemistry , Apoptosis/drug effects , Apoptotic Protease-Activating Factor 1/genetics , Apoptotic Protease-Activating Factor 1/metabolism , Caspase 3/genetics , Caspase 3/metabolism , Caspase 9/genetics , Caspase 9/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Chemistry, Pharmaceutical , Cytochromes c/genetics , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Humans , Mitochondria/drug effects , Mitochondria/metabolism , Particle Size , Polylactic Acid-Polyglycolic Acid Copolymer , Reactive Oxygen Species/metabolism , Skin Neoplasms , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism , Melanoma, Cutaneous Malignant
11.
Environ Toxicol Pharmacol ; 36(3): 937-47, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24035924

ABSTRACT

This study evaluates the possible protective potentials of chelidonine and its poly lactide-co-glycolide (PLGA) encapsulated nano-form against cadmium chloride (CdCl2) induced oxidative stress and hepatotoxicity in mice, ex vivo and in vivo. Acute exposure to CdCl2 (1.0 mg/kg b.w; i.p., twice a week for 30 days) generated oxidative stress in mice through accumulation of reactive oxygen species and increased lipid peroxidation, and levels of certain liver marker enzymes (ALT, AST, ALP) with decrease in levels of GSH and certain other antioxidant enzymes (SOD, CAT, GR) in liver. Treatment with nano-chelidonine for 30 days after CdCl2 intoxication significantly reduced oxidative stress and lipid peroxidation and restored levels of GSH, cholesterol, triglyceride and antioxidant enzymes, showing ameliorative changes in histopathology of liver. Expression pattern of certain inflammatory and apoptotic signal proteins also indicated better hepato-protective abilities of nano-chelidonine, making it a more suitable protective drug than chelidonine against cadmium toxicity in mice.


Subject(s)
Benzophenanthridines/chemistry , Cadmium Chloride/antagonists & inhibitors , Cadmium Chloride/toxicity , Cadmium Poisoning/prevention & control , Chelidonium/chemistry , Chemical and Drug Induced Liver Injury/prevention & control , Drug Compounding/methods , Lactic Acid/chemistry , Oxidative Stress/drug effects , Polyglycolic Acid/chemistry , Algorithms , Animals , Benzophenanthridines/administration & dosage , Benzophenanthridines/pharmacokinetics , Cell Survival/drug effects , Chemical and Drug Induced Liver Injury/pathology , Excipients , Hepatocytes/drug effects , Immunohistochemistry , Indicators and Reagents , Light , Mice , Nanoparticles , Nanotechnology , Particle Size , Polylactic Acid-Polyglycolic Acid Copolymer , Scattering, Radiation , Spectrophotometry, Atomic
12.
J Acupunct Meridian Stud ; 6(4): 180-7, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23972240

ABSTRACT

Cancer is a disease that needs a multi-faceted approach from different systems of medicine. The purpose of this study was to evaluate whether homeopathically-potentized ultra-high dilutions of Lycopodium Clavatum (LC-5C and LC-15C, respectively) have any anti-cancer effects on HeLa cells. Cells were exposed to either LC-5C (diluted below Avogadro's limit, i.e., 10(-10)) or LC-15C (diluted beyond Avogadro's limit, i.e., 10(-30)) (drug-treated) or to 30% succussed ethanol ("vehicle" of the drug). The drug-induced modulation in the percent cell viability, the onset of apoptosis, and changes in the expressions of Bax, Bcl2, caspase 3, and Apaf proteins in inter-nucleosomal DNA, in mitochondrial membrane potentials and in the release of cytochrome-c were analyzed by utilizing different experimental protocols. Results revealed that administration of LC-5C and LC-15C had little or no cytotoxic effect in normal peripheral blood mononuclear cells, but caused considerable cell death through apoptosis in cancer (HeLa) cells, which was evident from the induction of DNA fragmentation, the increases in the expressions of protein and mRNA of caspase 3 and Bax, and the decreases in the expressions of Bcl2 and Apaf and in the release of cytochrome-c. Thus, the highly-diluted, dynamized homeopathic remedies LC-5C and LC-15C demonstrated their capabilities to induce apoptosis in cancer cells, signifying their possible use as supportive medicines in cancer therapy.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Lycopodium/chemistry , Neoplasms/drug therapy , Plant Extracts/pharmacology , Apoptosis/drug effects , Caspase 3/genetics , Caspase 3/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , DNA Fragmentation/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Humans , Membrane Potential, Mitochondrial/drug effects , Neoplasms/genetics , Neoplasms/metabolism , Neoplasms/physiopathology , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism
13.
J Acupunct Meridian Stud ; 6(4): 188-98, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23972241

ABSTRACT

Extract of Myrica cerifera bark has long been fruitfully used as a hepato-protective and anti-cancer drug in various complementary and alternative systems of medicine. Myricanone, its principal bioactive compound, had also been reported to have apoptosis-promoting ability. We evaluated its anti-cancer potential in vitro in HepG2 liver cancer cells and tried to understand the signal cascades involved in accomplishing apoptosis. Further, we ascertained by using a (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay (MTT) assay if it had cytotoxic effects on normal noncancerous liver cells (WRL-68). We deployed various tools and protocols, like phase contrast, scanning electron and fluorescence microscopies, performed an annexinV-FITC/PI assay and cell cycle analysis, and estimated the reactive oxygen species (ROS) generation and mitochondrial membrane depolarization through flow cytometry. Further, analyses of cytochrome-c translocation and of HSP70 and caspase expressions were also done by using immunoblota and Enzyme linked immunosorbent assay (ELISA). Results revealed that myricanone induced apoptosis in HepG2 cells through generation of ROS, depolarization of the mitochondrial membrane, early release of cytochrome-c, down-regulation of HSP70 and activation of a caspase cascade; it had no, or insignificant, cytotoxic effects in WRL-68 cells in vitro and in mice in vivo. Thus, myricanone has great potential for use in formulating an effective drug against both hepatotoxicity and hepatocellular cancer.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Carcinoma, Hepatocellular/drug therapy , Diarylheptanoids/pharmacology , Liver Neoplasms/drug therapy , Myrica/chemistry , Plant Extracts/pharmacology , Animals , Antineoplastic Agents, Phytogenic/chemistry , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/physiopathology , Cell Cycle/drug effects , Cytochromes c/metabolism , Diarylheptanoids/chemistry , Hep G2 Cells , Humans , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Liver Neoplasms/physiopathology , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Plant Extracts/chemistry , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects
14.
Toxicol Lett ; 222(1): 10-22, 2013 Sep 12.
Article in English | MEDLINE | ID: mdl-23850776

ABSTRACT

Poor oral bioavailability of chelidonine, a bio-active ingredient of Chelidonium majus, showing anti-cancer potentials against cancer cells with multidrug resistance, makes its optimal use rather limited. To address this problem, we encapsulated chelidonine in biodegradable poly(lactide-co-glycolide) (PLGA) polymers and evaluated nano-chelidonine's (NCs) anti-cancer efficacy vis-à-vis free chelidonine (FC) against HepG2 cells and also evaluated its bioavailability in mice. Physicochemical characteristics indicated that stable spherical NC were formed in nanometer size range (123±1.15 nm) with good yield (86.34±1.91%), better encapsulation efficiency (82.6±0.574%), negative surface charge (-19.6±2.48 mV) and ability of prolonged and sustained release of chelidonine. Fourier transform infrared analysis revealed that NC resembled similar peaks as that of FC suggesting effective encapsulation in PLGA. NC exhibited rapid cellular uptake and stronger apoptotic effect (∼46.6% reduced IC50 value) than FC, blocking HepG2 cells at G2/M phase. p53, cyclin-D1, Bax, Bcl-2, cytochrome c, Apaf-1, caspase-9 and caspase-3 expressions also corroborated well to suggest greater anticancer potentials of NC. Our in vivo studies demonstrated NC to be more bio-available than FC and showed a better tissue distribution profile without inducing any toxicity (100 mg/kg bw) in mice. Unlike FC, NC could permeate into brain tissue, indicating thereby NC's better potentials for use in therapeutic oncology.


Subject(s)
Apoptosis/drug effects , Benzophenanthridines/pharmacology , Benzophenanthridines/pharmacokinetics , Cell Survival/drug effects , Central Nervous System Depressants/pharmacology , Central Nervous System Depressants/pharmacokinetics , Signal Transduction/drug effects , Animals , Biological Availability , Blotting, Western , Cell Cycle/drug effects , Cell Line, Tumor , Cytosol/metabolism , Drug Delivery Systems , Drug Stability , Excipients , Lactic Acid , Mice , Microscopy, Atomic Force , Microscopy, Fluorescence , Mitochondria/metabolism , Nanoparticles , Nucleosomes/drug effects , Nucleosomes/ultrastructure , Particle Size , Polyglycolic Acid , Polylactic Acid-Polyglycolic Acid Copolymer , Spectroscopy, Fourier Transform Infrared , Static Electricity
15.
Colloids Surf B Biointerfaces ; 109: 10-9, 2013 Sep 01.
Article in English | MEDLINE | ID: mdl-23603037

ABSTRACT

The present study evaluates relative efficacies of insulin and PLGA-loaded-nano-insulin (NIn) in combating arsenic-induced impairment of glucose uptake, insulin resistance and mitochondrial dysfunction in L6 skeletal muscle cells. L6 cells were treated with 0.5 mM sodium arsenite for 30 min and then the cells were further treated with either 100 nM insulin (standardized dose) or either of the two doses, 50 nM and 100 nM of nano-insulin. Various biomarkers like pyruvate-kinase and glucokinase, ATP/ADP ratio, mitochondrial membrane potential, cytosolic release of mitochondrial cytochrome c, cell membrane potential and calcium-ion level were studied and analyzed to ascertain the status of mitochondrial functioning in all experimental and control sets of L6 cells. The size, morphology and zeta potential of formulated NIn were determined by using dynamic light scattering, scanning electronic and atomic-force microscopies. Expression of signalling cascades like GLUT4, IRS1, IRS2, UCP2, PI3, and p38 was critically analyzed. Overall results suggested that both insulin and NIn improved mitochondrial functioning in arsenite-intoxicated L6 cells, NIn showing better effects at a much lower dose (at nearly 10-fold decreased dose) than that produced by insulin. Nano-insulin being non-toxic and effective at a much lesser dose, therefore, has potential for therapeutic use in the management of arsenic induced diabetes.


Subject(s)
Arsenic/toxicity , Insulin/pharmacology , Lactic Acid/pharmacology , Mitochondria/drug effects , Muscle, Skeletal/drug effects , Nanocapsules/chemistry , Polyglycolic Acid/pharmacology , Animals , Biomarkers/chemistry , Biomarkers/metabolism , Cell Line , Dose-Response Relationship, Drug , Glucose/metabolism , Insulin/chemistry , Insulin/metabolism , Insulin Resistance , Lactic Acid/chemistry , Lactic Acid/metabolism , Mitochondria/metabolism , Muscle, Skeletal/chemistry , Muscle, Skeletal/metabolism , Polyglycolic Acid/chemistry , Polyglycolic Acid/metabolism , Polylactic Acid-Polyglycolic Acid Copolymer , Rats , Structure-Activity Relationship
16.
Toxicol Appl Pharmacol ; 267(1): 57-73, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23276653

ABSTRACT

Diabetes is a menacing problem, particularly to inhabitants of groundwater arsenic contaminated areas needing new medical approaches. This study examines if PLGA loaded nano-insulin (NIn), administered either intraperitoneally (i.p.) or through oral route, has a greater cost-effective anti-hyperglycemic potential than that of insulin in chronically arsenite-fed hyperglycemic mice. The particle size, morphology and zeta potential of nano-insulin were determined using dynamic light scattering method, scanning electronic and atomic force microscopies. The ability of the nano-insulin (NIn) to cross the blood-brain barrier (BBB) was also checked. Circular dichroic spectroscopic (CD) data of insulin and nano-insulin in presence or absence of arsenic were compared. Several diabetic markers in different groups of experimental and control mice were assessed. The mitochondrial functioning through indices like cytochrome c, pyruvate-kinase, glucokinase, ATP/ADP ratio, mitochondrial membrane potential, cell membrane potential and calcium-ion level was also evaluated. Expressions of the relevant marker proteins and mRNAs like insulin, GLUT2, GLUT4, IRS1, IRS2, UCP2, PI3, PPARγ, CYP1A1, Bcl2, caspase3 and p38 for tracking-down the signaling cascade were also analyzed. Results revealed that i.p.-injected nano-encapsulated-insulin showed better results; NIn, due to its smaller size, faster mobility, site-specific release, could cross BBB and showed positive modulation in mitochondrial signaling cascades and other downstream signaling molecules in reducing arsenic-induced-hyperglycemia. CD data indicated that nano-insulin had less distorted secondary structure as compared with that of insulin in presence of arsenic. Thus, overall analyses revealed that PLGA nano-insulin showed better efficacy in combating arsenite-induced-hyperglycemia than that of insulin and therefore, has greater potentials for use in nano-encapsulated form.


Subject(s)
Arsenic/toxicity , Hyperglycemia/chemically induced , Hyperglycemia/prevention & control , Insulin/administration & dosage , Lactic Acid/administration & dosage , Nanoparticles/administration & dosage , Polyglycolic Acid/administration & dosage , Animals , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Drug Carriers/administration & dosage , Drug Carriers/chemistry , Drug Carriers/metabolism , Female , Hyperglycemia/metabolism , Insulin/chemistry , Insulin/metabolism , Lactic Acid/chemistry , Lactic Acid/metabolism , Male , Mice , Nanoparticles/chemistry , Polyglycolic Acid/chemistry , Polyglycolic Acid/metabolism , Polylactic Acid-Polyglycolic Acid Copolymer , Random Allocation
17.
Colloids Surf B Biointerfaces ; 101: 325-36, 2013 Jan 01.
Article in English | MEDLINE | ID: mdl-23010037

ABSTRACT

The capability of crude ethanolic extracts of certain medicinal plants like Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis used as homeopathic mother tinctures in precipitating silver nanoparticles from aqueous solution of silver nitrate has been explored. Nanoparticles thus precipitated were characterized by spectroscopic, dynamic light scattering, X-ray diffraction, atomic force and transmission electron microscopic analyses. The drug-DNA interactions of silver nanoparticles were analyzed from data of circular dichroism spectroscopy and melting temperature profiles using calf thymus DNA (CT-DNA) as target. Biological activities of silver nanoparticles of different origin were then tested to evaluate their effective anti-proliferative and anti-bacterial properties, if any, by exposing them to A375 skin melanoma cells and to Escherichia coli C, respectively. Silver nanoparticles showed differences in their level of anti-cancer and anti-bacterial potentials. The nanoparticles of different origin interacted differently with CT-DNA, showing differences in their binding capacities. Particle size differences of the nanoparticles could be attributed for causing differences in their cellular entry and biological action. The ethanolic extracts of these plants had not been tested earlier for their possible efficacies in synthesizing nanoparticles from silver nitrate solution that had beneficial biological action, opening up a possibility of having therapeutic values in the management of diseases including cancer.


Subject(s)
Cell Division/drug effects , Cell Survival/drug effects , G2 Phase/drug effects , Gelsemium/chemistry , Hydrastis/chemistry , Nanoparticles/chemistry , Phytolacca dodecandra/chemistry , Silver/chemistry , Thuja/chemistry , Biphenyl Compounds/chemistry , Cell Line , Circular Dichroism , Comet Assay , DNA Damage , Escherichia coli/drug effects , Ethanol , Free Radical Scavengers/chemistry , Free Radical Scavengers/pharmacology , Microbial Sensitivity Tests , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Particle Size , Picrates/chemistry , Real-Time Polymerase Chain Reaction , Silver Nitrate/chemistry , Solvents , Spectrophotometry, Ultraviolet , X-Ray Diffraction
18.
Phytother Res ; 27(5): 664-71, 2013 May.
Article in English | MEDLINE | ID: mdl-22744955

ABSTRACT

Dihydroxy-isosteviol methyl ester (DIME), the principal biological compound isolated from the medicinal plant Pulsatilla nigricans (Fam: Ranunculaceae) having the molecular formula of C21 H34 O3 (molecular weight 334.25), was administered to cervical cancer cells (HeLa) in vitro to evaluate its possible apoptotic (anti-cancer) potentials. We analyzed the expression of p53, Bax, Bcl2, Apaf and caspase 3 signal proteins and analyzed the early apoptotic events in HeLa cells induced by DIME using protocols like Annexin V-FITC and PI staining. DIME caused a significant decrease in cell viability, induced nuclear condensation and inter-nucleosomal DNA fragmentation. We further studied the interaction of DIME with calf thymus DNA as target through circular-dichroism spectra. Results showed that DIME interacted with DNA, bringing indiscernible changes in structure and conformation. Thus, DIME showed its capability to induce apoptosis in cancer cells, signifying its utility in drug design as a possible candidate for chemoprevention.


Subject(s)
Apoptosis/drug effects , DNA/chemistry , Diterpenes, Kaurane/pharmacology , Pulsatilla/chemistry , Animals , Cattle , Cell Survival , Comet Assay , DNA Fragmentation/drug effects , Diterpenes, Kaurane/chemistry , HeLa Cells , Humans
19.
Journal of Integrative Medicine ; (12): 405-15, 2013.
Article in English | WPRIM (Western Pacific) | ID: wpr-671832

ABSTRACT

To test if myricanone (C21H24O5), a cyclic diarylheptanoid, has anticancer effects on two different cancer cell lines HeLa and PC3. The present study was conducted with a note on the drug-DNA interaction and apoptotic signalling pathway.

20.
J Acupunct Meridian Stud ; 5(6): 310-8, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23265083

ABSTRACT

In South East Asia, groundwater arsenic contamination has become a great menace. Chronic arsenic intoxication leads to a hyperglycemic condition in animals and man. Because of undesirable side-effects and affordability, orthodox medicine, like insulin, is not preferred by many who like natural products instead. Unfortunately, such natural products mostly lack scientific validation. Therefore, we became interested in assessing the efficacy of the ethanolic seed extract of Syzygium jambolanum (SJ), traditionally used against diabetic conditions. We also formulated poly (lactic-co-glycolic) acid (PLGA)-encapsulated nano-SJ (NSJ) and tested whether the ameliorative potentials of SJ could be enhanced by nano-encapsulation. In this study, we conducted both in vitro (in L6 cells) and in vivo (in mice) experiments to assess the relative efficacy of SJ and NSJ. We characterized the physico-chemical features of NSJ by atomic force microscopy and critically analyzed several bio-markers and signal proteins associated with arsenic-induced stress and hyperglycemia. We also determined the relative ameliorative potentials of SJ and NSJ by using standard protocols. NSJ could cross the blood brain barrier in mice. Overall results suggested that NSJ had a greater potential than that of SJ, indicating the possibility of using NSJ in the future drug design and management of arsenic-induced hyperglycemia and stress.


Subject(s)
Arsenic/toxicity , Hyperglycemia/drug therapy , Hypoglycemic Agents/therapeutic use , Lactic Acid , Nanocapsules , Plant Extracts/therapeutic use , Polyglycolic Acid , Syzygium , Animals , Blood-Brain Barrier/metabolism , Cell Line , Female , Hyperglycemia/chemically induced , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/metabolism , Male , Mice , Mice, Inbred Strains , Plant Extracts/administration & dosage , Plant Extracts/metabolism , Polylactic Acid-Polyglycolic Acid Copolymer , Rats , Seeds
SELECTION OF CITATIONS
SEARCH DETAIL
...